Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
16.17
+0.41 (2.60%)
Jan 22, 2026, 1:00 PM EST - Market open
Avalo Therapeutics Market Cap
Avalo Therapeutics has a market cap or net worth of $299.35 million as of January 22, 2026. Its market cap has increased by 241.73% in one year.
Market Cap
299.35M
Enterprise Value
180.70M
1-Year Change
241.73%
Ranking
Category
Stock Price
$16.17
Market Cap Chart
Since November 13, 2015, Avalo Therapeutics's market cap has increased from $34.50M to $299.35M, an increase of 767.68%. That is a compound annual growth rate of 23.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 268.40M | -18.49% |
| Dec 31, 2025 | 329.30M | 326.55% |
| Dec 31, 2024 | 77.20M | 957.53% |
| Dec 29, 2023 | 7.30M | -84.60% |
| Dec 30, 2022 | 47.40M | -75.17% |
| Dec 31, 2021 | 190.90M | -3.49% |
| Dec 31, 2020 | 197.80M | -16.79% |
| Dec 31, 2019 | 237.70M | 80.35% |
| Dec 31, 2018 | 131.80M | 58.03% |
| Dec 29, 2017 | 83.40M | 917.07% |
| Dec 30, 2016 | 8.20M | -71.63% |
| Dec 31, 2015 | 28.90M | -16.23% |
| Nov 13, 2015 | 34.50M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abeona Therapeutics | 287.76M |
| Aldeyra Therapeutics | 285.77M |
| Palisade Bio | 281.62M |
| Shattuck Labs | 274.63M |
| OmniAb | 274.24M |
| Larimar Therapeutics | 273.89M |
| Crescent Biopharma | 273.69M |
| Neurogene | 271.38M |